Table 4.
Cluster | R2 | Adjusted R2 | Std. Error of the Estimate | R2 Change | Sig. F Change |
---|---|---|---|---|---|
1. Sociodemographic | 0.21 | 0.20 | 0.90 | 21% | <0.01* |
2. Clinical | 0.23 | 0.20 | 0.90 | 2% | 0.41 |
3. Physical | 0.25 | 0.19 | 0.90 | 1% | 0.53 |
4. Mental | 0.25 | 0.18 | 0.91 | 1% | 0.83 |
Unstandardized Coefficients |
Standardized Coefficients |
||||
Variables of final model (4) | B | Std. Error | Beta | Sig. | |
(Constant) | 0.01 | 10.20 | 0.99 | ||
Sex | 0.57 | 0.15 | 0.28 | <0.01* | |
Age | −0.01 | 0.01 | −0.11 | 0.14 | |
Education | 0.58 | 0.15 | 0.29 | <0.01* | |
Hemisphere | 0.16 | 0.16 | 0.08 | 0.31 | |
Antiepileptic drugs | 0.09 | 0.18 | 0.04 | 0.61 | |
Radiotherapy | 0.13 | 0.15 | 0.06 | 0.40 | |
Chemotherapy | −0.15 | 0.27 | −0.04 | 0.59 | |
Disease duration | −0.01 | 0.01 | −0.06 | 0.47 | |
SF-36 physical component summary score | 0.00 | 0.01 | 0.00 | 0.97 | |
QLQ BN-20 visual disorder | 0.05 | 0.05 | 0.08 | 0.36 | |
QLQ BN-20 motor dysfunction | −0.06 | 0.06 | −0.08 | 0.35 | |
SF-36 mental component summary score | 0.00 | 0.01 | 0.02 | 0.86 | |
MFI mental fatigue | −0.01 | 0.02 | −0.03 | 0.68 | |
QLQ BN-20 communication deficit | −0.04 | 0.04 | −0.09 | 0.32 | |
QLQ BN-20 future uncertainty | 0.02 | 0.03 | 0.04 | 0.64 |
Abbreviations: MFI, Multidimensional Fatigue Inventory; QLQ BN-20, Brain cancer specific Quality of Life Questionnaire; SF-36, Medical Outcomes Study Short-Form 36; Std., standard; Sig., significant.